257 related articles for article (PubMed ID: 28940408)
1. Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium.
Álvarez E; Paradela-Dobarro B; Raposeiras-Roubín S; González-Juanatey JR
Br J Clin Pharmacol; 2018 Feb; 84(2):280-291. PubMed ID: 28940408
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity.
Carter RLR; Talbot K; Hur WS; Meixner SC; Van Der Gugten JG; Holmes DT; Côté HCF; Kastrup CJ; Smith TW; Lee AYY; Pryzdial ELG
J Thromb Haemost; 2018 Nov; 16(11):2276-2288. PubMed ID: 30176116
[TBL] [Abstract][Full Text] [Related]
3. Edoxaban's contribution to key endothelial cell functions.
Almengló C; Mosquera-Garrote N; González-Peteiro M; González-Juanatey JR; Álvarez E
Biochem Pharmacol; 2020 Aug; 178():114063. PubMed ID: 32492447
[TBL] [Abstract][Full Text] [Related]
4. [Effect of rivaroxaban on the injury during endotoxin-induced damage to human umbilical vein endothelial cells].
Shi M; Huang J; Sun X; Wang F; Chu X; Jiang R; Wang Y; Pang L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Apr; 31(4):468-473. PubMed ID: 31109423
[TBL] [Abstract][Full Text] [Related]
5. Regulatory effects of estetrol on the endothelial plasminogen pathway and endothelial cell migration.
Montt-Guevara MM; Palla G; Spina S; Bernacchi G; Cecchi E; Campelo AE; Shortrede JE; Canu A; Simoncini T
Maturitas; 2017 May; 99():1-9. PubMed ID: 28364860
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa/FXa.
Ku SK; Bae JS
Arch Pharm Res; 2014 Nov; 37(11):1454-63. PubMed ID: 24817443
[TBL] [Abstract][Full Text] [Related]
7. Demeanor of rivaroxaban in activated/inactivated FXa.
Seki K; Mizuno Y; Sakashita T; Nakano S; Tanno J; Okazaki Y; Muramatsu T; Nishimura S; Senbonmatsu T
J Pharmacol Sci; 2017 Mar; 133(3):156-161. PubMed ID: 28314697
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosuvastatin on fibrinolytic system of human umbilical vein endothelial cells in vitro.
He F; Zhao J; Guo R; Liang Y
Am J Med Sci; 2014 Oct; 348(4):319-23. PubMed ID: 24694789
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
Petzold T; Thienel M; Dannenberg L; Mourikis P; Helten C; Ayhan A; M'Pembele R; Achilles A; Trojovky K; Konsek D; Zhang Z; Regenauer R; Pircher J; Ehrlich A; Lüsebrink E; Nicolai L; Stocker TJ; Brandl R; Röschenthaler F; Strecker J; Saleh I; Spannagl M; Mayr CH; Schiller HB; Jung C; Gerdes N; Hoffmann T; Levkau B; Hohlfeld T; Zeus T; Schulz C; Kelm M; Polzin A
Circ Res; 2020 Feb; 126(4):486-500. PubMed ID: 31859592
[TBL] [Abstract][Full Text] [Related]
11. Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.
Abou-Agag LH; Aikens ML; Tabengwa EM; Benza RL; Shows SR; Grenett HE; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):155-62. PubMed ID: 11236827
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro.
Wojta J; Zoellner H; Gallicchio M; Filonzi EL; Hamilton JA; McGrath K
Lymphokine Cytokine Res; 1994 Apr; 13(2):133-8. PubMed ID: 8061114
[TBL] [Abstract][Full Text] [Related]
13. Activation of human vascular endothelial cells by factor Xa: effect of specific inhibitors.
Herault JP; Bono F; Avril C; Schaeffer P; Herbert JM
Biochem Pharmacol; 1999 Mar; 57(6):603-10. PubMed ID: 10037444
[TBL] [Abstract][Full Text] [Related]
14. Ability of retroviral transduction to modify the angiogenic characteristics of RPE cells.
Sakamoto T; Spee C; Scuric Z; Gordon EM; Hinton DR; Anderson WF; Ryan SJ
Graefes Arch Clin Exp Ophthalmol; 1998 Mar; 236(3):220-9. PubMed ID: 9541827
[TBL] [Abstract][Full Text] [Related]
15. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
16. Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.
Fukao H; Ueshima S; Tanaka N; Okada K; Matsuo O
Thromb Res Suppl; 1990; 10():11-20. PubMed ID: 2107596
[TBL] [Abstract][Full Text] [Related]
17. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
18. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
19. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
Muth H; Maus U; Wygrecka M; Lohmeyer J; Grimminger F; Seeger W; Günther A
Crit Care Med; 2004 Jan; 32(1):217-26. PubMed ID: 14707582
[TBL] [Abstract][Full Text] [Related]
20. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
